Bertrand Joly
Corbeil-essonnes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.
Journal: British journal of haematology
Published: October 24, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
Journal: Nature medicine
Published: April 18, 2024
Posterior reversible encephalopathy syndrome (PRES) and myeloma.
Journal: Leukemia research reports
Published: September 30, 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Journal: Haematologica
Published: June 29, 2023
Correction: Impact of nutritional status on heart failure mortality: a retrospective cohort study.
Journal: Nutrition journal
Published: September 28, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline.
Journal: Haematologica
Published: May 30, 2022
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Journal: Haematologica
Published: February 08, 2022
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2022
Impact of nutritional status on heart failure mortality: a retrospective cohort study.
Journal: Nutrition journal
Published: July 12, 2021
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.
Journal: American journal of hematology
Published: April 21, 2021
Last Updated: 09/26/2026